Colitis, Ulcerative Clinical Trials in New York, New York

7 studies are recruiting for colitis, ulcerative in New York, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)

   Researchers want to learn more about tulisokibart (also known as MK-7240) in an extension study. Tulisokibart is a medicine designed to treat active, moderate to severe Crohn's disease (CD) and ulcerative colitis (UC). An extension study is a type of study where people who received tulisokibart in …

   Stage

   Phase 3

   Ages

   Any age

   Site

   New York Gastroenterology Associates ( Site 0253), New York, New York

   Locations

   37 in total

   Run by

   Merck Sharp & Dohme LLC

   See if you can join NCT06651281 on ClinicalTrials.gov

2. A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis

   The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the co…

   Stage

   Phase 3

   Ages

   12 and older

   Site

   Inflammatory Bowel Disease Center at NYU Langone, New York, New York

   Locations

   401 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07196748 on ClinicalTrials.gov

3. A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis

   The purpose of this study is to assess how well JNJ-78934804 works (efficacy) and how safe it is (safety) as compared to guselkumab at Week 48 in participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   New York Gastroenterology Associates, New York, New York

   Locations

   170 in total

   Run by

   Janssen Research & Development, LLC

   See if you can join NCT07577856 on ClinicalTrials.gov

4. A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis

   This is a Phase 2, multicenter, proof-of-concept platform study in adult participants with moderately to severely active ulcerative colitis (UC). The primary goal of the study is to assess the efficacy and safety of multiple interventions following intravenous (IV) induction and subcutaneous (SC) m…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Site 037, New York, New York

   Locations

   267 in total

   Run by

   Spyre Therapeutics, Inc.

   See if you can join NCT07012395 on ClinicalTrials.gov

5. A Study of How the Medicine Called "Etrasimod" Works in Children With the Gut Disease Called Ulcerative Colitis

   The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in pediatrics participants (≥ 2 years up to < 12 years of age). Participants who will complete the total 52-week treatment per…

   Stage

   Phase 2

   Ages

   2 to 11

   Site

   Fink Children's Ambulatory Care Center, New York, New York

   Locations

   42 in total

   Run by

   Pfizer

   See if you can join NCT07470879 on ClinicalTrials.gov

6. A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis

   The purpose of this study is to evaluate the effectiveness and safety of ozanimod (RPC1063) in achieving and maintaining clinical remission. Ozanimod will be administered orally to pediatric participants with moderate to severe active ulcerative colitis (UC) who have had an inadequate response to c…

   Stage

   Phase 2

   Ages

   2 to 17

   Site

   Columbia University Medical Center, New York, New York

   Locations

   90 in total

   Run by

   Bristol-Myers Squibb

   See if you can join NCT05076175 on ClinicalTrials.gov

7. An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis

   The purpose of this observational study is to learn about the effects of etrasimod as a treatment for adult patients with moderate to severe ulcerative colitis. Patients will be treated according to standard of care and will only be included in the study if etrasimod is the best treatment of choice…

   Stage

   Not phased

   Ages

   18 to 64

   Site

   NYU Langone Health, New York, New York

   Locations

   28 in total

   Run by

   Pfizer

   See if you can join NCT06398626 on ClinicalTrials.gov